Exploring Small Molecules Targeting Protein-Protein Interactions (PPIs): Advancements and Future Prospects
1NanoBio Lab, School of Engineering, Widener University, Chester, PA 19013, USA.
Pharmaceuticals (Basel, Switzerland)
|December 23, 2023
Summary
This special issue explores small molecules that target protein-protein interactions (PPIs) for new drug development. It covers current strategies for designing these innovative therapeutics.
Area of Science:
- Pharmaceutical sciences, medicinal chemistry, and drug discovery.
Background:
- Protein-protein interactions (PPIs) are crucial in cellular processes, making them attractive targets for novel therapeutics.
- Dysregulated PPIs are implicated in numerous diseases, including cancer and infectious diseases, highlighting the need for targeted interventions.
Discussion:
- This issue reviews current strategies for developing small molecule inhibitors and modulators of PPIs.
- Challenges in targeting PPIs, such as large, flat binding interfaces, are discussed alongside innovative approaches to overcome them.
Key Insights:
- Small molecules offer a promising avenue for modulating PPIs, complementing traditional drug discovery approaches.
- Advances in structural biology and computational chemistry are accelerating the design of potent and selective PPI inhibitors.
Outlook:
- Future research will focus on expanding the scope of druggable PPIs and refining drug design methodologies.
- The development of novel small molecule PPI modulators holds significant potential for treating a wide range of unmet medical needs.
More Related Videos
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.6K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.0K
Related Concept Videos
02:04Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
02:26Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
02:40Ligand Binding Sites
12.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.9K
02:04Protein-Protein Interfaces
3.8K
3.8K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:16Protein-Drug Binding: Mechanism and Kinetics
512
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
512